BridgeMD
New treatment option for Chalazion
Official title Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery
ClinicalTrials.gov ID: NCT07450495
What this study is testing
What is Sevoflurane?
Sevoflurane is an investigational medicine, given as an inhaled treatment, being studied as a potential treatment for chalazion.
Also referred to as Sevorane,Sevorane,Ultane.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized controlled trial aims to compare the effectiveness and safety of 6% versus 8% sevoflurane inhalation induction in pediatric patients undergoing minor ophthalmic surgery. The primary outcome is emergence agitation assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 6
You may be able to join if
- Children aged 1 to 6 years (12-72 months)
- Scheduled to undergo minor ophthalmic surgery (e.g., chalazion excision) under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I
- Assessed as suitable for inhalation anesthesia by anesthesiologists
- Written informed consent obtained from parents or legal guardians
You likely can't join if
- ASA physical status II or higher
- Known hepatic or renal dysfunction
- Congenital heart disease
- History of malignant hyperthermia
- Known allergy to sevoflurane
- History of asthma or severe respiratory disease
See the full eligibility criteria
- Children aged 1 to 6 years (12-72 months)
- Scheduled to undergo minor ophthalmic surgery (e.g., chalazion excision) under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I
- Assessed as suitable for inhalation anesthesia by anesthesiologists
- Written informed consent obtained from parents or legal guardians
- ASA physical status II or higher
- Known hepatic or renal dysfunction
- Congenital heart disease
- History of malignant hyperthermia
- Known allergy to sevoflurane
- History of asthma or severe respiratory disease
- Upper respiratory tract infection within the past 4 weeks
- Anticipated difficult airway
- Refusal of participation by parents or legal guardians
The study team makes the final eligibility decision.
Where it's taking place
- Shantou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shantou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.